Dangerous Ingredient Found in Weight Loss Products
The FDA is advising consumers to not buy or use Infinity capsules or Lite Fit USA softgels, products marketed and sold for weight loss.
A laboratory analysis showed these products were found to contain sibutramine. Sibutramine was a Schedule IV substance that was voluntarily withdrawn from the market in October 2010 following evidence supporting potentially serious cardiovascular adverse effects.
Sibutramine may pose a significant risk for patients with prior coronary artery disease, congestive heart failure, arrhythmias, or stroke. These supplements may also pose life-threatening interactions with other medications a consumer may be taking.
For more information call (855) 543-3784 or visit FDA.gov.